Screening compound: C19H22FN3O4S (T651-0074)

Screening compound: C<sub>19</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>4</sub>S (T651-0074)
Screening compound: C<sub>19</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>4</sub>S (T651-0074) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C19H22FN3O4S (T651-0074)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T651-0074

Molecular Formula

C19H22FN3O4S (C19 H22 FN3 O4 S)

Compound Name

N-{8-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]-8-azabicyclo[3.2.1]octan-3-yl}-4-fluorobenzamide

IUPAC name

N-[(1R5S)-8-[(35-dimethyl-12-oxazol-4-yl)sulfonyl]-8-azabicyclo[3.2.1]octan-3-yl]-4-fluorobenzamide

SMILES

Cc1noc(C)c1S(N([C@H](CC1)C2)[C@@H]1CC2NC(c(cc1)ccc1F)=O)(=O)=O

InChI

InChI=1S/C19H22FN3O4S/c1-11-18(12(2)27-22-11)28(25,26)23-16-7-8-17(23)10-15(9-16)21-19(24)13-3-5-14(20)6-4-13/h3-6,15-17H,7-10H2,1-2H3,(H,21,24)/t15?,16-,17+

InChI Key

WNAFSIAFZBLHFI-ALOPSCKCSA-N

MDL Number (MFCD)

C19H22FN3O4S (T651-0074) in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Bromodomain Modulators Library (5801 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • GPCR
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C19H22FN3O4S (T651-0074) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C19H22FN3O4S (T651-0074)?
Check Price and Availability of C19H22FN3O4S (T651-0074), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C19H22FN3O4S (T651-0074) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C19H22FN3O4S (T651-0074)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C19H22FN3O4S (T651-0074)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C19H22FN3O4S (T651-0074) available by request